Integrative Physiology/Experimental Medicine |
From the Wallace H. Coulter Department of Biomedical Engineering (C.L.D., S.T.R., R.E.G., W.R.T.), Georgia Institute of Technology and Emory University, Atlanta; the Division of Cardiology, Department of Medicine (D.W., F.M.F.A., W.R.T.), Emory University, Atlanta; Woodruff School of Mechanical Engineering (R.E.G.), Georgia Institute of Technology, Atlanta; and the Veterans Affairs Medical Center (W.R.T.), Decatur, Ga.
Correspondence to W. Robert Taylor, MD, PhD, Emory University School of Medicine, Cardiology Division, 1639 Pierce Drive, Suite 319 WMB, Atlanta, GA 30322. E-mail wtaylor{at}emory.edu
Abstract
Objective— Osteopontin (OPN) is a highly phosphorylated extracellular matrix glycoprotein that is involved in a diversity of biological processes. In the vascular wall, OPN is produced by monocytes/macrophages, endothelial cells, and smooth muscle cells, and it is thought to mediate adhesion, migration, and survival of these cell types. In this study, we hypothesized that OPN plays a critical role in recovery from limb ischemia.
Methods and Results— We induced hind limb ischemia in wild-type and OPN–/– mice. OPN–/– mice exhibited significantly delayed recovery of ischemic foot perfusion as determined by LDPI, impaired collateral vessel formation as measured using micro-CT, and diminished functional capacity of the ischemic limb. In the aortic ring assay, normal endothelial cell sprouting was found in OPN–/– mice. However, OPN–/– peritoneal monocytes/macrophages were found to possess significantly reduced migration in response to chemoattraction.
Conclusions— This study provides evidence that a definitive biological role exists for OPN during ischemic limb revascularization, and we have suggested that this may be driven by impaired monocyte/macrophage migration in OPN–/– mice. These findings provide the first in vivo evidence that OPN may be a key regulator in postnatal vascular growth.
We investigated the role of osteopontin (OPN) in recovery from hind limb ischemia. OPN–/– mice exhibited delayed ischemic limb recovery, which may be attributable to defective response of OPN–/– monocytes/macrophages to chemoattraction. These results provide the first evidence that a role exists for OPN during ischemic limb revascularization in vivo.
Key Words: osteopontin hind limb ischemia angiogenesis arteriogenesis collateral vessels
This article has been cited by other articles:
![]() |
L. Lam Shang Leen, C. Filipe, A. Billon, B. Garmy-Susini, S. Jalvy, F. Robbesyn, D. Daret, C. Allieres, S. R. Rittling, N. Werner, et al. Estrogen-Stimulated Endothelial Repair Requires Osteopontin Arterioscler Thromb Vasc Biol, December 1, 2008; 28(12): 2131 - 2136. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Tressel, H. Kim, C.-W. Ni, K. Chang, J. C. Velasquez-Castano, W. R. Taylor, Y.-s. Yoon, and H. Jo Angiopoietin-2 Stimulates Blood Flow Recovery After Femoral Artery Occlusion by Inducing Inflammation and Arteriogenesis Arterioscler Thromb Vasc Biol, November 1, 2008; 28(11): 1989 - 1995. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2008 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |